Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Kidney Medicine|August 1, 2020
Pilot Intervention Addressing Social Support and Functioning of Low Socioeconomic Status Older Adults With ESRD: The Seniors Optimizing Community Integration to Advance Better Living with ESRD (SOCIABLE) StudyDeidra C Crews, Alice M Delaney, Janiece L Walker Taylor, et al.
JCO Oncology Practice|April 2, 2021
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)Joshua A Roth, Meghna S Trivedi, Stacy W Gray, et al.
Ophthalmology|March 26, 2017
Panel-Based Clinical Genetic Testing in 85 Children with Inherited Retinal DiseaseRachel L Taylor, Neil R A Parry, Stephanie J Barton, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901Stephen D Barrett, Alexander J Bridges, David T Dudley, et al.
JAMA Network Open|January 10, 2025
Attributable Risk and Consequences of Bone Mineral Density Deficits in Childhood Cancer SurvivorsChelsea G Goodenough, Jessica L Baedke, Angela M Delaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaJennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
JAMA|February 25, 2015
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemiaBarthelemy Diouf, Kristine R Crews, Glen Lew, et al.
Birth Defects Research|March 25, 2022
Identifying possible inaccuracy in reported birth head circumference measurements among infants in the US Zika Pregnancy and Infant RegistryNicole M Roth, Kate R Woodworth, Shana Godfred-Cato, et al.
Molecular Cancer Therapeutics|July 9, 2008
Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitorAndrea J Gonzales, Kenneth E Hook, Irene W Althaus, et al.
Clinical and Translational Science|March 20, 2021
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristineBarthelemy Diouf, Claudia Wing, John C Panetta, et al.
Pageof 22